Conflict of Interest
Jennifer Doudna Disclosures
The Regents of the University of California have patents issued and pending for CRISPR technologies on which J.A.D. is an inventor.
J.A.D. is a cofounder of Azalea Therapeutics, Caribou Biosciences, Editas Medicine, Evercrisp, Scribe Therapeutics, Aurora Therapeutics, Intellia, and Mammoth Biosciences.
J.A.D. is a scientific advisory board member at BEVC Management, Evercrisp, Caribou Biosciences, Scribe Therapeutics, Isomorphic Labs, Mammoth Biosciences, The Column Group and Inari. She is also an advisor for Aditum Bio and Aurora Therapeutics.
J.A.D. is Chief Science Advisor to Sixth Street, a Director at Johnson & Johnson, Altos, and Tempus.
